| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mrz―16 |
CARDIOVASCULAR COMPLICATIONS OF COVID-19 VACCINATION, ITS DIAGNOSIS, PATHOGENESIS, AND TREATMENT: A REVIEW |
Minahil Fatima |
| 2 |
[GO] |
2025―Jan―15 |
EFFECTS OF TOCILIZUMAB AND SYSTEMIC CORTICOSTEROIDS IN PATIENTS WITH CARDIOVASCULAR DISEASE ON CLINICAL OUTCOMES IN COVID-19 |
Zudi Osmani, Belma Paralija, Rusmir Baljić |
| 3 |
[GO] |
2024―Jan―15 |
A HOLISTIC PERSPECTIVE ON THE IMPACT OF COVID-19 ON THE GLOBAL POPULATION IN TERMS OF MORBIDITY AND MORTALITY RATES: IS HUMANITY READY TO FACE FUTURE PANDEMICS? |
Mostafa Essam Eissa |
| 4 |
[GO] |
2023―Jan―15 |
COVID-19 KINETICS BASED ON REPORTED DAILY INCIDENCE IN HIGHLY DEVASTATED GEOGRAPHICAL REGION: A UNIQUE ANALYSIS APPROACH OF EPIDEMIC |
Mostafa Essam Eissa, Engy Refaat Rashed, Dalia Essam Eissa |
| 5 |
[GO] |
2022―Nov―20 |
KNOWLEDGE, CHARACTERISTICS, WORK SITES OF HEALTH PRACTITIONERS FOR CHEST PHYSIOTHERAPY IN PATIENTS WITH COVID-19, IN KHARTOUM, SUDAN |
Mohammed Elfatih Elbadri, Marina Victor, Randa Ibrahem, Aya Azhari, Mariam Essam, Ali Awadallah Saeed |
| 6 |
[GO] |
2022―Nov―20 |
COMPUTATIONAL DRUG REPROPOSING TO IDENTIFY SARS-COV-2 MPRO INHIBITORS: MOLECULAR DOCKING, ADMET ANALYSIS, AND IN-SILICO/IN-VITRO TOXICITY STUDY |
Mohammed Farrag El-Behairy, Marwa AA Fayed, Rasha M. Ahmed, Inas A. Abdallah |
| 7 |
[GO] |
2022―Jul―16 |
NIGELLA SATIVA L.: A GOLDEN REMEDY: SIGNIFICANCE WORLDWIDE HIGHLIGHTING THEIR POSSIBLE USE FOR COVID-19 |
Marwa A. A. Fayed |
| 8 |
[GO] |
2022―Jan―15 |
COVID-19 PANDEMIC AWARENESS AND ITS IMPACT ON BANGLADESHI PEOPLE: A COMMUNITY BASED SURVEY |
Md. Monirul Islam, Abu Zobayed, Md. Imran Nur Manik, Mohammad Asadujjaman |
| 9 |
[GO] |
2021―Jul―15 |
COVID-19 IN MEXICO: PREPARING FOR FUTURE PANDEMICS |
Benjamín Ruiz Loyola |
| 10 |
[GO] |
2021―Mai―15 |
EFFECTS OF NOVEL CORONAVIRUS DISEASE-19 (COVID-19) ON VITAL ORGANS IN PATIENTS INFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) |
M. Ibrahim Hossain, Esha Binte Shahriar, Anamika Sarker, Nafisa Lubna, Mehjabeen Haque, Md. Ibrahim Khalil |
| 11 |
[GO] |
2021―Mai―15 |
CLINICAL COURSE AND DISEASE OUTCOME IN COVID-19 PATIENTS WITH DIABETES MELLITUS |
Rusmir Baljic, Ahmed Velic, Amila Muhic, Refet Gojak, Belma Gazibera, Nermina Bajramovic, et al. (+2) Meliha Hadzovic- Cengic, Ilhama Huric |
| 12 |
[GO] |
2021―Mrz―15 |
ROLE OF AMBROXOL AS A PROPHYLACTIC AGENT AGAINST COVID-19 |
Azza M. Baraka, Wessam F. El-Hadidy |
| 13 |
[GO] |
2021―Mrz―15 |
THE ROLE OF ANTICOAGULANTS AND ANTIPLATELETS IN PROPHYLAXIS AND/OR TREATMENT OF SEVERE SARS-COV-2 INFECTION |
Wessam F. El-Hadidy, Asmaa A. Khalifa |
| 14 |
[GO] |
2021―Jan―16 |
COVID-19: CURRENT PHARMACOLOGICAL THERAPEUTIC APPROACHES |
Mai ES. Ghoneim, Asmaa A. Khalifa, Bassma M. Ali |
| 15 |
[GO] |
2020―Nov―18 |
TRADITIONAL TO RECENT APPROACHES IN HERBAL MEDICINE THERAPY OF COVID-19 |
Mohamed S. Refaey, Marwa A.A. Fayed |
| 16 |
[GO] |
2020―Nov―18 |
SUDANESE EXPERIENCE OF HERBAL FORMULAS USED DURING COVID-19 INFECTION |
AzzaAbdelilah Ahmed Mohamed, Mai Abdalla Humaida, Ali Awadallah Saeed |
| 17 |
[GO] |
2020―Sep―15 |
EUCALYPTUS ESSENTIAL OIL; AN OFF-LABEL USE TO PROTECT THE WORLD FROM COVID-19 PANDEMIC: REVIEW-BASED HYPOTHESES |
Hatem Sameir Abbass |
| 18 |
[GO] |
2020―Jul―15 |
THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT |
Ferrara F, De Rosa F, Pelliccia C, La Porta R, Vitiello A |
| 19 |
[GO] |
2020―Jul―15 |
USE OF COLCHICINE TO COUNTERACT THE STRONG HYPERINFLAMMATORY STATE INDUCED BY SARS-COV-2 |
Ferrara F, De Rosa F, Pelliccia C, La Porta R, Vitiello A |
